Form 8-K - Current report

0000706698 false false false false false false 0000706698 2024-05-03 2024-05-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

 

Date of Report (date of earliest event reported): May 3, 2024

 

 

 Commission File No. 001-12575

 

 

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

 

UTAH			87-0342734
(State or other jurisdiction of			(IRS Employer
incorporation or organization)			Identification No.)

 

 

7043 South 300 West

Midvale, Utah  84047

Address of principal executive offices

 

 

Registrant's telephone number: [phone]

---

 

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

 

On May 3, 2024 at the Company’s annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration:

 

 

Elected Kevin L. Cornwell as a director of the Company: 

For  1,436,389Withheld1,304,680Broker Non Votes 324,644 

 

Elected Paul O. Richins as a director of the Company: 

For907,483Withheld1,833,586Broker Non Votes 324,644 

 

Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: 

For3,012,801Against49,443Abstentions 3,469 

 

Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: 

For2,662,106Against  72,899Abstentions 6,064     Broker Non Votes 324,644 

 

 

Per Company policy, Mr. Richins tendered his resignation, which was conditioned upon acceptance by the Board of Directors. The Board of Directors voted not to accept his resignation.  Per Utah law, Mr. Richins was elected to serve a three-year term and until his successor is elected and qualified.

 

The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials.  Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

---

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 

 

UTAH MEDICAL PRODUCTS, INC. 

REGISTRANT 

 

 

Date:        5/03/2024                   By:     /s/ Kevin L. Cornwell                          

    Kevin L. Cornwell 

    Chairman & CEO 

Document and Entity Information	May 03, 2024
Details
Registrant CIK	0000706698
Registrant Name	UTAH MEDICAL PRODUCTS, INC.
SEC Form	8-K
Period End date	May 03, 2024
Tax Identification Number (TIN)	87-0342734
Emerging Growth Company	false
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Securities Act File Number	001-12575
Entity Incorporation, State or Country Code	UT
Entity Address, Address Line One	7043 South 300 West
Entity Address, City or Town	Midvale
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84047
City Area Code	801
Local Phone Number	566-1200
Amendment Flag	false

---